Recent share performance and what it might signal

Procter & Gamble (PG) has seen its share price under pressure recently, with a 0.6% decline over the past day, about 5.5% over the past week, and around 11% over the past month.

For longer term holders, the stock shows a small decline over the past 3 months and around 9.7% negative total return over the past year, while the year to date move remains slightly positive.

The recent 1 month share price return of an 11% decline, alongside a 1 year total shareholder return of a 9.68% decline, suggests momentum has faded even though long term shareholders still show positive total returns over 3 and 5 years.

If this shift in sentiment has you reassessing your watchlist, it could be a good time to scan the market using a focused list of 20 top founder-led companies

With Procter & Gamble trading at $143.16 alongside an indicated discount to some analyst price targets and intrinsic value estimates, is this a potential opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 18.3% Overvalued

According to the most followed narrative, Procter & Gamble's fair value of $121.06 sits meaningfully below the last close at $143.16, which frames the current pullback in a different light.

Procter & Gamble, despite being within a very competitive industry, still has some competitive advantages. This is shown in its higher operating margin above the ~20% mark and the Morning Star Wide Moat. Also, the fact that the ROIC is double the Cost of Capital means its capital allocation is being well managed. Its solid Moodys Debt Rating along with the Low Uncertainty Morningstar rating maintains the company as a stable and reliable investment if the opportunity arises.

The narrative leans heavily on a mix of strong profitability, disciplined capital allocation, and measured growth assumptions. It blends moderate revenue and earnings growth, wide margins, and a specific required return into one fair value number, while also weighing how mature a global consumer staples group can realistically grow from here.

Result: Fair Value of $121.06 (OVERVALUED)

However, this narrative could be challenged if revenue growth slows below the recent 3.3% level or if profitability metrics weaken and undermine the wide moat case.

Another valuation angle: SWS DCF model

While the most popular community view lands on a fair value of $121.06 and calls Procter & Gamble overvalued at $143.16, the SWS DCF model points in the opposite direction. It places future cash flow value at $203.99, suggesting the current price sits at a sizable discount. Which framework do you think fits your expectations for this business?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Procter & Gamble for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 58 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of signals feels mixed to you, that is exactly the point. Look through both the risks and the potential rewards so you can judge the balance for yourself with 4 key rewards and 2 important warning signs

Looking for more investment ideas?

Do not stop with a single company view. Use this pullback as a prompt to refresh your watchlist with ideas that match your goals and risk comfort.

• Target resilient cash generators by scanning for companies on the 58 high quality undervalued stocks that combine quality fundamentals with prices below their estimated worth.
• Build a steadier income stream by reviewing potential high yield candidates through the 13 dividend fortresses while checking how those payouts might fit your long term plans.
• Aim for stronger downside protection by focusing on companies highlighted in the 73 resilient stocks with low risk scores that show more robust risk profiles than the broader market.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.